CRISPR Therapeutics
Daniela Colombo is a seasoned finance professional with extensive experience in accounting and financial management across multiple industries. Currently serving as a Senior Accounting Manager at CRISPR Therapeutics, Daniela oversees the Swiss treasury function, manages month-end accounting close, prepares financial statements, coordinates tax filings, and ensures compliance with local and global regulations. Previous roles include Senior Accountant positions at Luxoft and Gentium GmbH, where Daniela managed multiple entities and ensured accurate financial reporting in accordance with US GAAP. Early career experiences include roles as Finance Manager at Springer Healthcare Italia and Finance Manager at Avanade, alongside positions in financial control and administration at Sun Microsystems. Daniela also possesses a diverse educational background with qualifications in vibrational coaching, quantum therapy, and reflexology.
This person is not in any offices
CRISPR Therapeutics
11 followers
CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9